The what, where, and how of resolvins

Asia-Pacific Journal of Molecular Biology and Biotechnology

Volumn 20, Issue 2, 2012, Pages 45-54

  Dwivedi, Shivani ^a   Patel, Sapan ^a   Jain, Kapil ^a  

^a People's College of Dental Sciences   (India)

Author keywords

Antibiotic; Antiinflammatory; Antimicrobial; Inflammatory response; Resolvins

Indexed keywords

EID: 84874843761     PISSN: 01287451     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A. and Serhan, C.N. 2005. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega 3 lipid mediator resolvin E1. Journal of Experimental Medicine 201: 713-722.
2. Arita, M., Oh, S.F., Chonan, T., Hong, S., Elangovan, S., Sun, Y.P., Uddin, J., Petasis, N.A. and Serhan, C.N. 2006. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. Journal of Biological Chemistry 281: 22847-22854.
3. Arita, M., Ohira, T., Sun, Y.P., Elangovan, S., Chiang, N. and Serhan, C.N. 2007. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Journal of Immunology 178: 3912-3917.
4. Bannenberg, G.L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K.H., Hong, S. and Serhan, C.N. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. Journal of Immunology 174: 4345-4355.
5. Burr, G.O. and Burr, M.M. 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. The Journal of Biological Chemistry 82: 345-67.
6. Campbell, E.L., Louis, N.A., Tomassetti, S.E., Canny, G.O., Arita, M., Serhan, C.N. and Colgan, S.P. 2007. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. Federation of American Societies for Experimental Biology 21: 3162-3170.
7. Claria, J. and Serhan C.N. 1995. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. The Proceedings of the National Academy of Sciences USA 92: 9475-9479.
8. Cotran, R.S., Kumar, V. and Collins, T. Eds. Robbins Pathologic Basis of Disease, W.B. Saunders Co., Philadelphia, Pennsylvania, USA.
9. Damazo, A.S., Yona, S., Flower, R.J., Perretti, M. and Oliani S.M. 2006. Spatial and temporal profiles for antiinflammatory gene expression in leukocytes during a resolving model of peritonitis. Journal of Immunology 176: 4410-4418.
10. Dona, M., Fredman, G., Schwab, J.M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U.H. and Serhan, C.N. 2008. Resolvin E1, an EPA-derived mediator in whole blood, selectively counter regulates leukocytes and platelets. Blood 112: 848-855.
11. Duffield, J.S., Hong, S., Vaidya, V.S., Lu, Y., Fredman, G., Serhan, C.N. and Bonventre, J.V. 2006. Resolvin D series and protectin D1 mitigate acute kidney injury. Journal of Immunology 177: 5902-5911.
12. Elkhouli, A.M. 2011. The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (Clinical and biochemical study): a randomized, double-blind, placebo-controlled study. Journal of Periodontal Research 46: 261-268.
13. El-Sharkawy, H., Aboelsaad, N., Eliwa, M., Darweesh, M., Alshahat, M., Kantarci, A., Hasturk, H. and Van Dyke, T.E. 2010. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and low-dose aspirin. Journal of Periodontology 81, 1635-1643.
14. Filer, A., Pitzalis, C. and Buckley, C.D. 2006. Targeting the stromal microenvironment in chronic inflammation. Current Opinions in Pharmacology 6: 393-400.
15. Gallin, J.I., Synderman, R., Fearon, D.T., Haynes, B.F. and Nathan, C. 1999. Inflammation: Basic Principles and clinical correlates(Lippincott Williams & Wilkins, Philadelphia).
16. Haas-Stapleton, E.J. 2007. Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. Public Library of Science One Journal 2: e1316.
17. Hamazaki, K., Itomura, M., Sawazaki, S. and Hamazaki, T. 2006. Fish oil reduces tooth loss mainly through its anti-inflammatory effects? Medical Hypotheses Journal 67: 868-70.
18. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N.A., Levy, B.D., Serhan, C.N. and Van Dyke, T.E. 2006. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. The Journal of the Federation of American Societies for Experimental Biology 20(2): 401-403.
19. Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C.N. and Van Dyke, T.E. 2007. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Journal of Immunology 179: 7021-7029.
20. Haworth, O., Cernadas, M., Yang, R., Serhan, C.N. and Levy, B.D. 2008. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nature Immunology 9: 873-879.
21. Seki, H., Sasaki, T., Ueda, T. and Arita, M. 2010. Resolvins as regulators of the immune system. The Scientific World Journal 10: 818-83.
22. Hong, S., Gronert, K., Devchand, P., Moussignac, R.L. and Serhan, C.N. 2003. Novel docosatrienes and 17Sresolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. Journal of Biological Chemistry 278: 14677-14687.
23. Hong, S., Lu, Y., Yang, R., Gotlinger, K.H., Petasis, N.A. and Serhan, C.N. 2007. Resolvin D1, protectin D1, and related docosahexaenoic acidderived products: analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mecha- nisms. Journal of the American Society for Mass Spectrometry 18: 128-144.
24. Holtzman, M.J., Turk, J. and Shornick, L.P. 1992. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. Journal of Biological Chemistry 267(30): 21438-21445.
25. Iwasaky, M., Yoshihara, A., Moynihan, P., Watanabe, R., Taylor, G.W. and Miyazaki, H. 2010. Longitudinal relationship between dietary omega-3 fatty acids and periodontal disease. Nutrition 26: 1105-1109.
26. James, M.J., Proudman, S.M. and Cleland, L.G. 2003. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids 68: 399-405.
27. Jin, Y., Arita, M., Zhang, Q., Saban, D.R., Chauhan, S.K., Chiang, N., Serhan, C.N. and Dana, R. 2009. Antiangiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Investigative Ophthalmology and Visual Science 50: 4743-4752.
28. Kasuga, K., Yang, R., Porter, T.F., Agrawal, N., Petasis, N.A., Irimia, D., Toner, M. and Serhan, C.N. 2008. Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution. The Journal of immunology 181(12): 8677-8687.
29. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. and Serhan, C.N. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunology 2: 612-619.
30. Maderna, P. and Godson, C. 2005. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins, Leukotrienes and Essential Fatty Acids 73: 179-187.
31. Majno, G. and Joris, I. 2004. Cells, Tissues, and Disease: Principles of General Pathology. New York: Oxford University Press.
32. Marcheselli, V.L., Hong, S., Lukiw, W.J., Hua Tian, X., Gronert, K., Musto, A., Hardy, M., Gimenez, J.M., Chiang, N., Serhan, C.N. and Bazan, N.G. 2003. Novel docosanoids inhibit brain ischemia-reperfusionmediated leukocyte infiltration and pro-inflammatory gene expression. Journal of Biological Chemistry 278: 43807-43817.
33. Tonetti, M.S., Chapple, I.L. and Working Group 3 of the Seventh European Workshop on Periodontology. 2011. Biological approaches to the development of novel periodontal therapies - Consensus of the Seventh European Workshop on Periodontology. Journal of Clinical Periodontology 38 (Suppl. 11): 114-118.
34. Navia, M.A. and Peattie, D.A. 1993. Structure-based drug design: Applications in immunopharmacology and immunosuppression. Immunology Today 14: 296-302.
35. Patrono, C. and Baigent, C. 2009. Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. Molecular Interventions 9(1): 31-39.
36. Rodriguez, A.R. and Spur, B.W. 2004. First total synthesis of 7(S), 16(R), 17(S)-resolvin D2, a potent antiinflammatory lipid mediator. Tetrahedron letters 45: 8717-8720.
37. Schwab, J.M., Chiang, N., Arita, M. and Serhan, C.N. 2004. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.
38. Serhan, C.N. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunology 2: 612-619.
39. Serhan, C.N. 2002. Lipoxins and aspirin-triggered 15-epilipoxin biosynthesis: an update and role in anti-inflammation and proresolution. Prostaglandins and Other Lipid Mediators 68-69: 433-455.
40. Serhan, C.N. 2004. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochemistry and Cell Biology 122: 305-321.
41. Serhan, C.N. 2005. Special Issue on Lipoxins and Aspirin-Triggered Lipoxins. Prostaglandins, Leukotrienes and Essential Fatty Acids 73: 139-321.
42. Serhan, C.N. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual Review of Immunology 25: 101-137.
43. Serhan, C.N. 2008. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. Journal of Periodontology 79: 1520-1526.
44. Serhan, C.N. and Chiang, N. 2004. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics. Rheumatic Disease Clinics of North America 30: 69-95.
45. Serhan, C.N., Clish, C.B., Brannon, J., Colgan, S.P., Chiang, N. and Gronert, K. 2000. Novel functional sets of lipid-derived mediators with anti inflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. Journal of Experimental Medicine 192: 1197-1204.
46. Serhan, C.N., Hong, S. and Lu, Y. 2006. Lipid Mediator Informatics-Lipidomics: Novel Pathways in Mapping Resolution. American Association of Pharmaceuticals Scientists Journal 8(2): E284-E297.
47. Serhan, C.N. and Savill, J. 2005. Resolution of inflammation: the beginning programs the end. Nature Immunology 6: 1191-1197.
48. Serhan, C.N., Maddox, J.F., Petasis, N.A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H.R., Colgan, S.P. and Madara, J.L. 1995. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34: 14609-14615.
49. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G. and Moussignac, R.L. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signal. Journal of Experimental Medicine 196: 1025-1037.
50. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., Perretti, M., Rossi, A.G. and Wallace, J.L. 2007. Resolution of inflammation: state of the art, definitions and terms. The Journal of the Federation of American Societies for Experimental Biology 21: 325-332.
51. Spite, M., Norling, L.V., Summers, L., Yang, R., Cooper, D., Petasis, N.A., Flower, R.J., Perretti, M. and Serhan, C.N. 2009. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461: 1287-1291.
52. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A. and Serhan, C.N. 2007. Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties and enzymatic inactivation. Journal of Biological Chemistry 282: 9323-9334.
53. Tian, H., Lu, Y., Sherwood, A.M., Hongqian, D. and Hong, S. 2009. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Investigative Ophthalmology and Visual Science 50: 3613-3620.
54. Van Dyke, T.E. 2008. The management of inflammation in periodontal disease. Journal of Periodontology 79:1601-1608.
55. Vassiliou, E.K., Kesler, O.M., Tadros, J.H. and Ganea, D. 2008. Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells. Journal of Immunology 181: 4534-4544.